BTIG Maintains Buy on OrthoPediatrics, Lowers Price Target to $52
Portfolio Pulse from Benzinga Newsdesk
BTIG analyst Ryan Zimmerman has maintained a 'Buy' rating on OrthoPediatrics (NASDAQ:KIDS) but lowered the price target from $59 to $52.
October 04, 2023 | 9:14 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
OrthoPediatrics' price target has been lowered from $59 to $52 by BTIG, though the 'Buy' rating is maintained.
The lowering of the price target by BTIG could potentially create a negative sentiment among investors, which might put downward pressure on the stock price. However, the maintained 'Buy' rating indicates that the analyst still sees potential upside, which could counterbalance the negative sentiment.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100